Neuromyelitis optica spectrum disorders without and with autoimmune diseases

BMC Neurology

Volumn 14, Issue 1, 2014, Pages

  Zhang, Bingjun ^a   Zhong, Yi ^a   Wang, Yanqiang ^a   Dai, Yongqiang ^a   Qiu, Wei ^a   Zhang, Lei ^a   Li, Haiyan ^a   Lu, Zhengqi ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Autoantibodies; Magnetic resonance imaging; Neuromyelitis optica; Neuromyelitis optica spectrum disorder; Non organ specific autoimmune diseases; Organ specific autoimmune diseases

Indexed keywords

C REACTIVE PROTEIN; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G; RO ANTIBODY; SM ANTIBODY; THYROGLOBULIN ANTIBODY; THYROXINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FREE THYROXINE INDEX; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NEUROMYELITIS OPTICA SPECTRUM DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AUTOIMMUNE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA;

EID: 84910093119     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/s12883-014-0162-7     Document Type: Article

References (34)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6:805-815. 10.1016/S1474-4422(07)70216-8, 17706564.
2. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489. 10.1212/01.wnl.0000216139.44259.74, 16717206.
3. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112. 10.1016/S0140-6736(04)17551-X, 15589308.
4. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008, 65:78-83. 18195142.
5. Nagaishi A, Takagi M, Umemura A, Tanaka M, Kitagawa Y, Matsui M, Nishizawa M, Sakimura K, Tanaka K. Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes. J Neurol Neurosurg Psychiatry 2011, 82:1360-1364. 10.1136/jnnp-2011-300403, 21665917.
6. Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D, Melamud L, Marta M, Graham A, Spillane J, Villa AM, Callegaro D, Santos E, da Silva AM, Jarius S, Howard R, Nakashima I, Giovannoni G, Buckley C, Hilton-Jones D, Vincent A, Palace J. Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 2012, 78:1601-1607. 10.1212/WNL.0b013e31825644ff, 22551731.
7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725. 10.1002/art.1780400928, 9324032.
8. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schiodt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, et al. American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res 2012, 64:475-487. 10.1002/acr.21591.
9. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 2010(62):2569-2581. 10.1002/art.27584.
10. Mosca M, Tani C, Carli L, Bombardieri S. Undifferentiated CTD: a wide spectrum of autoimmune diseases. Best Pract Res Clin Rheumatol 2012, 26:73-77. 10.1016/j.berh.2012.01.005, 22424194.
11. Takahashi T, Miyazawa I, Misu T, Takano R, Nakashima I, Fujihara K, Tobita M, Itoyama Y. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry 2008, 79:1075-1078. 10.1136/jnnp.2008.145391, 18420727.
12. Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005, 65:1479-1482. 10.1212/01.wnl.0000183151.19351.82, 16275842.
13. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006, 63:964-968. 10.1001/archneur.63.7.964, 16831965.
14. Elsone L, Townsend T, Mutch K, Das K, Boggild M, Nurmikko T, Jacob A. Neuropathic pruritus (itch) in neuromyelitis optica. Mult Scler 2013, 19:475-479. 10.1177/1352458512457720, 22936333.
15. Kanamori Y, Nakashima I, Takai Y, Nishiyama S, Kuroda H, Takahashi T, Kanaoka-Suzuki C, Misu T, Fujihara K, Itoyama Y. Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study. Neurology 2011, 77:652-658. 10.1212/WNL.0b013e318229e694, 21813781.
16. de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier-Vehier F, Verier A, Pruvo JP, Hache JC, Vermersch P. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 2002, 197:57-61. 10.1016/S0022-510X(02)00043-6, 11997067.
17. Jacob A, McKeon A, Nakashima I, Sato DK, Elsone L, Fujihara K, de Seze J. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry 2013, 84:922-930. 10.1136/jnnp-2012-302310, 23142960.
18. Hummers LK, Krishnan C, Casciola-Rosen L, Rosen A, Morris S, Mahoney JA, Kerr DA, Wigley FM. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 2004, 62:147-149. 10.1212/01.WNL.0000101715.32569.1A, 14718721.
19. Wingerchuk DM, Weinshenker BG. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 2012, 18:5-10. 10.1177/1352458511431077, 22146604.
20. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473-477. 10.1084/jem.20050304, 16087714.
21. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006, 59:566-569. 10.1002/ana.20770, 16453327.
22. Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008, 70:2197-2200. 10.1212/01.wnl.0000303817.82134.da, 18434643.
23. Jarius S, Jacobi C, de Seze J, Zephir H, Paul F, Franciotta D, Rommer P, Mader S, Kleiter I, Reindl M, Akman-Demir G, Seifert-Held T, Kristoferitsch W, Melms A, Wandinger KP, Wildemann B. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 2011, 17:1067-1073. 10.1177/1352458511403958, 21543553.
24. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006, 63:390-396. 10.1001/archneur.63.3.390, 16533966.
25. Cabrera-Gomez JA, Quevedo-Sotolongo L, Gonzalez-Quevedo A, Lima S, Real-Gonzalez Y, Cristofol-Corominas M, Romero-Garcia K, Ugarte-Sanchez C, Jordan-Gonzalez J, de la Nuez JE, Lahera JG, Tellez R, Pedroso-Ibanez I, Roca RR, Cabrera-Nunez AY. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica. Mult Scler 2007, 13:186-192. 10.1177/1352458506070725, 17439883.
26. Kim W, Kim SH, Lee SH, Li XF, Kim HJ. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler 2011, 17:1107-1112. 10.1177/1352458511404917, 21543554.
27. Wang F, Liu Y, Duan Y, Li K. Brain MRI abnormalities in neuromyelitis optica. Eur J Radiol 2011, 80:445-449. 10.1016/j.ejrad.2010.06.024, 20884147.
28. Matthews L, Marasco R, Jenkinson M, Kuker W, Luppe S, Leite MI, Giorgio A, De Stefano N, Robertson N, Johansen-Berg H, Evangelou N, Palace J. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 2013, 80:1330-1337. 10.1212/WNL.0b013e3182887957, 23486868.
29. Min JH, Kim HJ, Kim BJ, Lee KW, Sunwoo IN, Kim SM, Kim BJ, Kim SH, Park MS, Waters P, Vincent A, Sung JJ, Lee KH. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Mult Scler 2009, 15:1069-1076. 10.1177/1352458509106228, 19625331.
30. Kim W, Park MS, Lee SH, Kim SH, Jung IJ, Takahashi T, Misu T, Fujihara K, Kim HJ. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler 2010, 16:1229-1236. 10.1177/1352458510376640, 20685766.
31. Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, Watanabe S, Takahashi T, Nishiyama S, Shiga Y, Sato S, Weinshenker BG, Itoyama Y. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006, 77:1073-1075. 10.1136/jnnp.2005.080390, 16505005.
32. Lu Z, Zhang B, Qiu W, Kang Z, Shen L, Long Y, Huang J, Hu X. Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. PLoS One 2011, 6:e22766. 10.1371/journal.pone.0022766, 21853047.
33. Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica. Neurologist 2007, 13:2-11. 10.1097/01.nrl.0000250927.21903.f8, 17215722.
34. Downer JJ, Leite MI, Carter R, Palace J, Kuker W, Quaghebeur G. Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?. Neuroradiology 2012, 54:279-285. 10.1007/s00234-011-0875-x, 21553012.